Building on decades of landmark HIV prevention research, our experts are now increasing the evidence base on how to reduce barriers and enhance opportunities for the effective use of antiretroviral (ARV)-based products by women. A special issue of the Journal of the International AIDS Society (funded by the U.S. Agency for International Development) presented topics ranging from adherence and risk perception to the potential roles for partners, communities, providers and the private sector, which programs must address to support women’s use of ARVs for HIV prevention. The dissemination of research in peer-reviewed publications has broad impact on the practices of program implementers and scientists.
FHI 360’s scientific research continues to be at the forefront of efforts to evaluate a variety of safe, effective HIV prevention methods, so that women can choose methods that best suit their lifestyles and preferences. … Read more
Amy Corneli, PhD, MPH
Scientist, Social and Behavioral Health Sciences